Early work by Yokoyama et al. showed that Menin was essential for MLL-FP leukemogenesis [86] and Grembecka et al. used Menin-MLL structural data to develop specific Menin-MLL small molecule inhibitors that disrupt the growth of MLL-FP leukemias [88]. This evidence concerns the gene KMT2A and leukemia.